To address the molecular mechanisms underlying the KRAS mutation dependent, TIMP-1 associated effects on CRC cells, we performed gene expression profiling of KRAS wt and KRAS G13D mutated CRC cells stimulated or not with TIMP-1. This evidence concerns the gene TIMP1 and colorectal carcinoma.